← Back to patent-cliff list
Clindamycin phosphate/Benzoyl Peroxide
Tier C — Watch / tradeClindamycin phosphate/Benzoyl Peroxide
Valeant
Originator
2000
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：50S ribosomal subunit
Brand：Benzaclin
Indications (approved)：Acne vulgaris
Regional status
US
Withdrawn
EU
-
China
Approved
2019-09-29
Japan
Approved
2015-03-26
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Clindamycin phosphate/Benzoyl Peroxide?
Approved indications include: Acne vulgaris.
When does the Clindamycin phosphate/Benzoyl Peroxide patent expire?
No public expiry year is available for Clindamycin phosphate/Benzoyl Peroxide yet; this page updates once verified.
How do I get a quote for Clindamycin phosphate/Benzoyl Peroxide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04